Free Trial

Eurofins Scient (OTCMKTS:ERFSF) Sees Strong Trading Volume - Time to Buy?

Eurofins Scient logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Eurofins Scient (ERFSF) experienced an unusually strong volume spike—about 32,948 shares traded, a 383% increase from the prior session—with the last trade at $77.65 (previous close $76.41).
  • Analyst coverage is mixed: one Buy and three Hold ratings leave the stock with a MarketBeat consensus of "Hold", while BNP Paribas Exane upgraded to "outperform" and Citigroup reiterated "neutral."
  • Key fundamentals and technicals show a quick ratio of 1.19, current ratio of 1.26, debt-to-equity of 0.77, with the 50-day SMA at $79.99 (above the last trade) and the 200-day SMA at $74.96.
  • MarketBeat previews top five stocks to own in May.

Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) saw unusually-strong trading volume on Thursday . Approximately 32,948 shares were traded during trading, an increase of 383% from the previous session's volume of 6,825 shares.The stock last traded at $77.65 and had previously closed at $76.41.

Wall Street Analyst Weigh In

ERFSF has been the subject of several research reports. Citigroup reissued a "neutral" rating on shares of Eurofins Scient in a report on Monday, February 2nd. BNP Paribas Exane upgraded Eurofins Scient to an "outperform" rating in a research note on Monday, January 5th. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold".

Read Our Latest Research Report on Eurofins Scient

Eurofins Scient Stock Performance

The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77. The company's 50 day simple moving average is $79.99 and its 200-day simple moving average is $74.96.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines